doiSerbia

Relentless placoid chorioretinitis: A case report

Obradović Ljiljana (Health Center Kragujevac, Kragujevac)
Jovanović Svetlana (Clinical Center Kragujevac, Clinic of Ophthalmology, Kragujevac)
Petrović Nenad (Clinical Center Kragujevac, Clinic of Ophthalmology, Kragujevac)
Srećković Sunčica (Clinical Center Kragujevac, Clinic of Ophthalmology, Kragujevac)
Jovanović Zorica (Faculty of Medical Sciences, Department of Pathophysiology, Kragujevac)

Introduction. Relentless placoid chorioretinitis is an entity which belongs to the group of an atypical intermediate form of primary inflammatory choriocapillaropathies, resembling both acute posterior multifocal placoid pigment epitheliopathy and serpiginous choroiditis, but the retinal distribution and clinical course are not the same. Because of this similarity this entity was termed “AMPPiginous”. This entity was first described by Jones et al. in 2000. The aim of our case report is to present a very specific case where the clinical course was progressive, with loss of vision in the affected eye. Case Outline. A 31-year-old man, with no previous ophthalmic diseases, was hospitalized at the Clinic of Ophthalmology, Clinical Center Kragujevac, because of a reduction of vision in the right eye, and scotoma and metamorphopsia in the left eye. The clinical course of retinal lesions in the left eye resembled the changes observed in acute posterior multifocal placoid pigment epitheliopathy, and the right eye changes were between acute posterior multifocal placoid pigment epitheliopathy and serpiginous choroiditis. The diagnosis of relentless placoid chorioretinitis was confirmed after clinical, laboratory, immunological, virological, and angiography examinations. Conclusion. The progressive clinical course of the disease, complemented by multimodal imaging and extensive laboratory diagnostics, has led us to the diagnosis of relentless placoid chorioretinitis. The combined anti-inflammatory and immunomodulatory therapy led to the stabilization of visual acuity of the left eye as opposed to the right, where there has been no recovery.

Keywords: anti-inflammatory therapy, immunomodulatory therapy, multimodal imaging, primary inflammatory choriocapillaropathies